Nathan Heath Patterson

Nathan Heath Patterson

Auto-generated profile, based on publicly available information

Nathan Heath Patterson

Mass Spectrometry Research Center, Vanderbilt University, Nashville, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TMTeresa Manzo
Teresa Manzo
BPBoone Prentice
Boone Prentice
KAKristin G. Anderson
Kristin G. Anderson
ARAyush Raman
Ayush Raman
ASAislyn Schalck
Aislyn Schalck
LNLuigi Nezi
Luigi Nezi
CD8+ T cells are master effectors of antitumor immunity, and their presence at tumor sites correlates with favorable outcomes. However, metabolic constraints imposed by the tumor microenvironment (TME) can dampen their ability to control tumor progression. We describe lipid accumulation in the TME areas of pancreatic ductal adenocarcinoma (PDA) populated by CD8+ T cells infiltrating both murine and human tumors. In this lipid-rich but otherwise nutrient-poor TME, access to using lipid metabolism becomes particularly valuable for sustaining cell functions. Here, we found that intrapancreatic CD8+ T cells progressively accumulate specific long-chain fatty acids (LCFAs), which, rather than provide a fuel source, impair their mitochondrial function and trigger major transcriptional reprogramming of pathways involved in lipid metabolism, with the subsequent reduction of fatty acid catabolism. In particular, intrapancreatic CD8+ T cells specifically exhibit down-regulation of the very-long-chain acyl-CoA dehydrogenase (VLCAD) enzyme, which exacerbates accumulation of LCFAs and very-long-chain fatty acids (VLCFAs) that mediate lipotoxicity. Metabolic reprogramming of tumor-specific T cells through enforced expression of ACADVL enabled enhanced intratumoral T cell survival and persistence in an engineered mouse model of PDA, overcoming one of the major hurdles to immunotherapy for PDA.

1 October 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
NPNathan Heath Patterson
Nathan Heath Patterson
MTMichael Tuck
Michael Tuck
RPRaf Van de Plas
Raf Van de Plas
RCRichard M. Caprioli
Richard M. Caprioli

30 November 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
MTMichael Tuck
Michael Tuck
LBLandry Blanc
Landry Blanc
RTRita Touti
Rita Touti
NPNathan Heath Patterson
Nathan Heath Patterson
SNSebastiaan Van Nuffel
Sebastiaan Van Nuffel
NDNicolas Desbenoit
Nicolas Desbenoit

1 October 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
NPNathan Heath Patterson
Nathan Heath Patterson
MTMichael Tuck
Michael Tuck
ALAdam Lewis
Adam Lewis
AKAlexis Kaushansky
Alexis Kaushansky
JNJeremy L. Norris
Jeremy L. Norris
RCRichard M. Caprioli
Richard M. Caprioli

11 May 2022 in Nature Methods
Verified
Journal Article
Closed access
PDF file
TMTrevor Manz
Trevor Manz
IGIlan Gold
Ilan Gold
NPNathan Heath Patterson
Nathan Heath Patterson
CMChuck McCallum
Chuck McCallum
MKMark S. Keller
Mark S. Keller
NGNils Gehlenborg
Nils Gehlenborg

13 May 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
DRDaniel J. Ryan
Daniel J. Ryan
NPNathan Heath Patterson
Nathan Heath Patterson
NPNicole E. Putnam
Nicole E. Putnam
AWAimee D. Wilde
Aimee D. Wilde
AWAndy Weiss
Andy Weiss
JSJeffrey M. Spraggins
Jeffrey M. Spraggins